|
Market Closed -
NYSE
16:00:03 2026-08-07 EDT
|
5-day change
|
1st Jan Change
|
|
135.42 USD
|
-0.27%
|
 |
+1.16%
|
+11.04%
|
|
07-30 |
AptarGroup Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook
|
MT
| |
07-30 |
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on February 5, 2026.
|
CI
| |
07-30 |
(ATR) AptarGroup, Inc. Expects Q3 Adjusted EPS Range $1.45 - $1.53
|
MT
| |
07-30 |
Earnings Flash (ATR) AptarGroup, Inc. Reports Q2 Revenue $1.03B, vs. FactSet Est of $1.01B
|
MT
| |
07-30 |
Earnings Flash (ATR) AptarGroup, Inc. Posts Q2 Adjusted EPS $1.42 per Share, vs. FactSet Est of $1.35
|
MT
| |
07-30 |
AptarGroup, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
|
CI
| |
07-16 |
AptarGroup Keeps Quarterly Dividend at $0.48 a Share, Payable Aug. 20 to Shareholders of Record July 30
|
MT
| |
07-16 |
Aptargroup, Inc Declares Quarterly Cash Dividend, Payable on August 20, 2026
|
CI
| |
05-06 |
AptarGroup, Inc. Introduces Patented Reloadable Airless Packaging Solution for Clarins Total Eye Lift Eye Cream
|
CI
| |
04-30 |
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on October 10, 2024.
|
CI
| |
04-30 |
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on February 5, 2026.
|
CI
| |
04-30 |
AptarGroup Q1 Adjusted Earnings Fall, Revenue Rises
|
MT
| |
04-30 |
(ATR) AptarGroup, Inc. Expects Q2 Adjusted EPS Range $1.32 - $1.40
|
MT
| |
04-30 |
Earnings Flash (ATR) AptarGroup, Inc. Reports Q1 Revenue $982.9M, vs. FactSet Est of $956.0M
|
MT
| |
04-30 |
Earnings Flash (ATR) AptarGroup, Inc. Posts Q1 Adjusted EPS $1.19 per Share, vs. FactSet Est of $1.15
|
MT
| |
04-30 |
AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
|
CI
| |
04-27 |
AptarGroup, Inc. Launches Inverted Lidless Dispensing Closures For Beauty And Personal Care Markets
|
CI
| |
04-23 |
AptarGroup Keeps Quarterly Dividend at $0.48 a Share, Payable May 27 to Shareholders of Record May 6
|
MT
| |
04-23 |
AptarGroup, Inc. Declares Quarterly Cash Dividend, Payable on May 27, 2026
|
CI
| |
04-08 |
Aptar Partners With Enable Injections for enFuse Digital Service
|
MT
| |
03-19 |
AptarGroup, Inc.?s Unidose Powder Nasal Delivery System Utilizes in ENA Respiratory Phase II Clinical Study of INNA-051
|
CI
| |
03-16 |
AptarGroup, Inc. Utilizes Proprietary Nasal Delivery System In LTR Pharma Limited?s Phase II Clinical Study For Spontan Nasal Spray
|
CI
| |
02-05 |
AptarGroup Q4 Non-GAAP Earnings Fall, Revenue Rises; Shares Advance After Hours
|
MT
| |
02-05 |
(ATR) AptarGroup, Inc. Expects Q1 Adjusted EPS Range $1.13 - $1.21
|
MT
| |
02-05 |
Earnings Flash (ATR) AptarGroup, Inc. Reports Q4 Revenue $962.7M, vs. FactSet Est of $878.6M
|
MT
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions | 
